John A. Bilello

2.6k total citations
54 papers, 2.1k citations indexed

About

John A. Bilello is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, John A. Bilello has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 23 papers in Virology and 12 papers in Epidemiology. Recurrent topics in John A. Bilello's work include HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (20 papers) and Virus-based gene therapy research (11 papers). John A. Bilello is often cited by papers focused on HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (20 papers) and Virus-based gene therapy research (11 papers). John A. Bilello collaborates with scholars based in United States, Germany and United Kingdom. John A. Bilello's co-authors include George L. Drusano, Rupert Vessey, Daniel S. Stein, Gavin C. Donaldson, Wayomi R. Perera, Tom Wilkinson, Gerry Hagan, Jadwiga A. Wedzicha, John R. Hurst and Sandra L. Preston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

John A. Bilello

52 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Bilello United States 27 604 583 486 351 302 54 2.1k
Tracy Fischer United States 23 583 1.0× 894 1.5× 704 1.4× 468 1.3× 216 0.7× 53 2.5k
Qing Ma United States 29 709 1.2× 508 0.9× 118 0.2× 531 1.5× 332 1.1× 164 2.8k
Gregory L. Austin United States 22 376 0.6× 301 0.5× 332 0.7× 576 1.6× 333 1.1× 55 2.3k
Mark Laughlin United States 18 1.2k 2.0× 731 1.3× 96 0.2× 447 1.3× 934 3.1× 33 2.4k
Wen‐Zhe Ho United States 32 486 0.8× 1.0k 1.7× 90 0.2× 996 2.8× 750 2.5× 111 3.6k
J. T. Fleming United States 16 191 0.3× 470 0.8× 130 0.3× 712 2.0× 154 0.5× 26 2.3k
Roy Robertson United Kingdom 31 599 1.0× 460 0.8× 153 0.3× 149 0.4× 928 3.1× 84 2.5k
Giuseppe Famularo Italy 26 249 0.4× 152 0.3× 279 0.6× 539 1.5× 276 0.9× 125 2.0k
Helen C. Steel South Africa 27 494 0.8× 166 0.3× 258 0.5× 509 1.5× 667 2.2× 93 2.2k
William Adler United States 35 325 0.5× 232 0.4× 120 0.2× 758 2.2× 588 1.9× 143 4.2k

Countries citing papers authored by John A. Bilello

Since Specialization
Citations

This map shows the geographic impact of John A. Bilello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Bilello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Bilello more than expected).

Fields of papers citing papers by John A. Bilello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Bilello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Bilello. The network helps show where John A. Bilello may publish in the future.

Co-authorship network of co-authors of John A. Bilello

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Bilello. A scholar is included among the top collaborators of John A. Bilello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Bilello. John A. Bilello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Jianhua, John A. Bilello, Darius Babusis, et al.. (2021). NRTIs tenofovir, TAF, TDF, and FTC are inactive against SARS-CoV-2. HIV Medicine. 22. 59–59.
2.
Bilello, John A.. (2016). Seeking an Objective Diagnosis of Depression. Biomarkers in Medicine. 10(8). 861–875. 34 indexed citations
3.
Fava, Maurizio, Karl Johe, Larry Ereshefsky, et al.. (2015). A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Molecular Psychiatry. 21(10). 1372–1380. 38 indexed citations
4.
Bilello, John A., Linda M. Thurmond, Katie Smith, et al.. (2015). MDDScore. The Journal of Clinical Psychiatry. 76(2). e199–e206. 35 indexed citations
5.
Smith, Katie, Perry F. Renshaw, & John A. Bilello. (2012). The diagnosis of depression: current and emerging methods. Comprehensive Psychiatry. 54(1). 1–6. 76 indexed citations
6.
Papakostas, George I., Richard C. Shelton, Gustavo Kinrys, et al.. (2011). Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Molecular Psychiatry. 18(3). 332–339. 148 indexed citations
7.
Pinto-Plata, Víctor, John Toso, Karen Lee, et al.. (2007). Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 62(7). 595–601. 164 indexed citations
8.
Hurst, John R., Gavin C. Donaldson, Wayomi R. Perera, et al.. (2006). Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 174(8). 867–874. 344 indexed citations
9.
Bilello, John A.. (2005). The Agony and Ecstasy of “OMIC” Technologies in Drug Development. Current Molecular Medicine. 5(1). 39–52. 47 indexed citations
10.
Drusano, George L., William T. Symonds, Daniel S. Stein, et al.. (2002). Pharmacodynamics of Abacavir in an In Vitro Hollow-Fiber Model System. Antimicrobial Agents and Chemotherapy. 46(2). 464–470. 28 indexed citations
11.
Drusano, George L., John A. Bilello, Sandra L. Preston, et al.. (2001). Hollow‐Fiber Unit Evaluation of a New Human Immunodeficiency Virus Type 1 Protease Inhibitor, BMS‐232632, for Determination of the Linked Pharmacodynamic Variable. The Journal of Infectious Diseases. 183(7). 1126–1129. 44 indexed citations
12.
Skowron, Gail, Daniel S. Stein, George L. Drusano, et al.. (1999). The Safety and Efficacy of Granulocyte‐Macrophage Colony‐Stimulating Factor (Sargramostim) Added to Indinavir‐ or Ritonavir‐Based Antiretroviral Therapy: A Randomized Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases. 180(4). 1064–1071. 22 indexed citations
13.
Bilello, John A., Kathleen A. Stellrecht, George L. Drusano, & Daniel S. Stein. (1996). Soluble Tumor Necrosis Factor-  Receptor Type II (sTNF RII) Correlates with Human Immunodeficiency Virus (HIV) RNA Copy Number in HIV-Infected Patients. The Journal of Infectious Diseases. 173(2). 464–467. 43 indexed citations
14.
Bilello, John A., Kathleen A. Stellrecht, John M. Leonard, et al.. (1996). Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrobial Agents and Chemotherapy. 40(6). 1491–1497. 72 indexed citations
15.
Bilello, John A., et al.. (1995). Reduction Of The In Vitro Activity Of A77003, An Inhibitor Of Human Immunodeficiency Virus Protease, By Human Serum  1 Acid Glycoprotein. The Journal of Infectious Diseases. 171(3). 546–551. 47 indexed citations
16.
Bilello, John A., G. Bauer, Michael N. Dudley, G A Cole, & George L. Drusano. (1994). Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrobial Agents and Chemotherapy. 38(6). 1386–1391. 63 indexed citations
17.
Martin, Stephen J., Timothy P. O’Neill, John A. Bilello, & Julie L. Eiseman. (1991). Lymphocyte transformation abnormalities in bovine immunodeficiency-like virus infected calves. Immunology Letters. 27(2). 81–84. 40 indexed citations
18.
Eiseman, Julie L., et al.. (1991). Effect of 3′azidothymidine administered in drinking water or by continuous infusion on the development of MAIDS. Antiviral Research. 16(4). 307–326. 13 indexed citations
19.
Bilello, John A., et al.. (1990). Use of a Neonatal Murine Retrovirus Model To Evaluate the Long‐Term Efficacy and Toxicity of Antiviral Agentsa. Annals of the New York Academy of Sciences. 616(1). 238–251. 5 indexed citations
20.
Bilello, John A., Victoria H. Freedman, & Seung-il Shin. (1977). Growth of Murine Sarcoma Virus-Transformed Rat Kidney Cells in Nude Mice: Absence of Induction of Host Endogenous Viruses 2. JNCI Journal of the National Cancer Institute. 58(6). 1691–1694. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026